Opko Health Inc stock price

Opko Health Inc latest news:


  • 10/26/2017 09:17:47

    BRIEF-Opko Health licensee Tesaro announces FDA approval of Varubi IV for delayed nausea, vomiting associated with ...

    Opko Health Inc(OPK): * Opko Health(OPK) licensee Tesaro (TSRO) announces FDA approval of Varubi IV for delayed nausea and vomiting associated with chemotherapy. * ‍Tesaro (TSRO) is expected to launch Varubi IV in November 2017​ Source text for Eikon: Further company coverage:

  • More trends:

    OpowerOPWR | Oppenheimer HoldingsOPY | Oracle CorporationORCL | OrangeORAN | Orbital ATKOA | Orbitz WorldwideOWW | Orchid Island CapitalORC | Orion Engineered Carbons S.AOEC | Orion Marine Group IncORN | Orix Corp AdsIX |